Skip to main content

Table 4 Null hypothesis probabilities for differences in centrality parameters between Phase4 targets and all targets tested in networks from different database sources, corrected for multiple testing across both centrality metric and target classes (Benjamini–Hochberg method)

From: Centrality of drug targets in protein networks

  1. Cells are coded according to statistical significance (uncorrected α = 0.05; dark green: significant, light green: marginal significance, N.S.: not significant). Red fonts indicate lower average (t-test) or median (non-parametric) centrality observed for Phase4 targets, regardless of significance